Literature DB >> 23146250

Differences in subcortical structures in young adolescents at familial risk for schizophrenia: a preliminary study.

Michael K Dougherty1, Hongbin Gu, Joshua Bizzell, Stacy Ramsey, Guido Gerig, Diana O Perkins, Aysenil Belger.   

Abstract

Schizophrenia has been associated with reduced volumes of subcortical structures on magnetic resonance imaging (MRI), but the relation of these reductions to familial risk for the disorder is unclear. We investigated the effect of familial risk for schizophrenia on regional subcortical volumes during adolescence, a period marked by steep maturational changes in brain structure and the emergence of psychotic symptoms. A group of 26 non-help-seeking, first-degree relatives of patients with schizophrenia and 43 matched healthy comparisons, between 9 and 18 years of age, underwent MRI scanning and were rated for the presence of prodromal symptoms. Five subcortical regions-of-interest were tested for group differences and group by age interactions, as well as correlations with low-level prodromal symptoms in the familial risk group. Relative to comparisons, familial risk subjects demonstrated greater positive volume-age relationships in hippocampus, putamen, and globus pallidus. These results suggest that relatives of individuals with schizophrenia exhibit structural abnormalities in the subcortex as early as pre-adolescence, which may reflect altered neurodevelopment of these regions.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23146250      PMCID: PMC3518556          DOI: 10.1016/j.pscychresns.2012.04.016

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  45 in total

Review 1.  Neuroanatomy of vulnerability to psychosis: a voxel-based meta-analysis.

Authors:  P Fusar-Poli; S Borgwardt; A Crescini; G Deste; Matthew J Kempton; S Lawrie; P Mc Guire; E Sacchetti
Journal:  Neurosci Biobehav Rev       Date:  2010-12-17       Impact factor: 8.989

Review 2.  Developmental pathology, dopamine, stress and schizophrenia.

Authors:  Daniel J Lodge; Anthony A Grace
Journal:  Int J Dev Neurosci       Date:  2010-08-19       Impact factor: 2.457

3.  Grey matter and cognitive deficits in young relatives of schizophrenia patients.

Authors:  Tejas S Bhojraj; Alan N Francis; Debra M Montrose; Matcheri S Keshavan
Journal:  Neuroimage       Date:  2010-03-31       Impact factor: 6.556

4.  Cerebellar development in childhood onset schizophrenia and non-psychotic siblings.

Authors:  Deanna Greenstein; Rhoshel Lenroot; Liv Clausen; Alex Chavez; A C Vaituzis; Lan Tran; Nitin Gogtay; Judith Rapoport
Journal:  Psychiatry Res       Date:  2011-07-30       Impact factor: 3.222

5.  Elevated functional connectivity along a corticostriatal loop and the mechanism of auditory/verbal hallucinations in patients with schizophrenia.

Authors:  Ralph E Hoffman; Thomas Fernandez; Brian Pittman; Michelle Hampson
Journal:  Biol Psychiatry       Date:  2010-12-08       Impact factor: 13.382

6.  Abnormal frontostriatal interactions in people with prodromal signs of psychosis: a multimodal imaging study.

Authors:  Paolo Fusar-Poli; Oliver D Howes; Paul Allen; Matthew Broome; Isabel Valli; Marie-Claude Asselin; Paul M Grasby; Philip K McGuire
Journal:  Arch Gen Psychiatry       Date:  2010-07

Review 7.  Childhood psychiatric disorders as anomalies in neurodevelopmental trajectories.

Authors:  Philip Shaw; Nitin Gogtay; Judith Rapoport
Journal:  Hum Brain Mapp       Date:  2010-06       Impact factor: 5.038

8.  Hippocampal volume development in healthy siblings of childhood-onset schizophrenia patients.

Authors:  Anand Mattai; Avinash Hosanagar; Brian Weisinger; Deanna Greenstein; Reva Stidd; Liv Clasen; Francois Lalonde; Judith Rapoport; Nitin Gogtay
Journal:  Am J Psychiatry       Date:  2011-01-18       Impact factor: 18.112

Review 9.  Childhood onset schizophrenia: support for a progressive neurodevelopmental disorder.

Authors:  Judith L Rapoport; Nitin Gogtay
Journal:  Int J Dev Neurosci       Date:  2010-10-16       Impact factor: 2.457

10.  Facial emotion processing in schizophrenia: a meta-analysis of functional neuroimaging data.

Authors:  Huijie Li; Raymond C K Chan; Grainne M McAlonan; Qi-yong Gong
Journal:  Schizophr Bull       Date:  2009-03-30       Impact factor: 9.306

View more
  5 in total

Review 1.  Gray matter alterations in schizophrenia high-risk youth and early-onset schizophrenia: a review of structural MRI findings.

Authors:  Benjamin K Brent; Heidi W Thermenos; Matcheri S Keshavan; Larry J Seidman
Journal:  Child Adolesc Psychiatr Clin N Am       Date:  2013-07-23

2.  Subcortical structure alterations impact language processing in individuals with schizophrenia and those at high genetic risk.

Authors:  Xiaobo Li; Margaret Black; Shugao Xia; Chenyang Zhan; Hilary C Bertisch; Craig A Branch; Lynn E DeLisi
Journal:  Schizophr Res       Date:  2015-09-18       Impact factor: 4.939

3.  Changes in White Matter Organization in Adolescent Offspring of Schizophrenia Patients.

Authors:  Max de Leeuw; Marc M Bohlken; René Cw Mandl; Manon Hj Hillegers; René S Kahn; Matthijs Vink
Journal:  Neuropsychopharmacology       Date:  2016-07-21       Impact factor: 7.853

4.  Clinical, Cognitive, and Neuroimaging Evidence of a Neurodevelopmental Continuum in Offspring of Probands With Schizophrenia and Bipolar Disorder.

Authors:  Gisela Sugranyes; Elena de la Serna; Roger Borras; Vanessa Sanchez-Gistau; Jose C Pariente; Soledad Romero; Inmaculada Baeza; Covadonga M Díaz-Caneja; Elisa Rodriguez-Toscano; Carmen Moreno; Miguel Bernardo; Dolores Moreno; Eduard Vieta; Josefina Castro-Fornieles
Journal:  Schizophr Bull       Date:  2017-10-21       Impact factor: 9.306

5.  Subcortical brain volume abnormalities in 2028 individuals with schizophrenia and 2540 healthy controls via the ENIGMA consortium.

Authors:  T G M van Erp; D P Hibar; J M Rasmussen; D C Glahn; G D Pearlson; O A Andreassen; I Agartz; L T Westlye; U K Haukvik; A M Dale; I Melle; C B Hartberg; O Gruber; B Kraemer; D Zilles; G Donohoe; S Kelly; C McDonald; D W Morris; D M Cannon; A Corvin; M W J Machielsen; L Koenders; L de Haan; D J Veltman; T D Satterthwaite; D H Wolf; R C Gur; R E Gur; S G Potkin; D H Mathalon; B A Mueller; A Preda; F Macciardi; S Ehrlich; E Walton; J Hass; V D Calhoun; H J Bockholt; S R Sponheim; J M Shoemaker; N E M van Haren; H E Hulshoff Pol; H E H Pol; R A Ophoff; R S Kahn; R Roiz-Santiañez; B Crespo-Facorro; L Wang; K I Alpert; E G Jönsson; R Dimitrova; C Bois; H C Whalley; A M McIntosh; S M Lawrie; R Hashimoto; P M Thompson; J A Turner
Journal:  Mol Psychiatry       Date:  2015-06-02       Impact factor: 15.992

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.